Skip to content
Menu

Nano Labs Ltd NA

Full chart Compare
Set alert

Price alert · NA

All alert types
0.81 USD -0.10 (-11.03%)

Regular-session close

0.86 +0.06 +7.30%

After hours · Nov 20, 4:00 PM ET

0.8001 Day range 0.9051
0.8001 52-week range 4.95
YTD
-74.43%
1 year
-83.73%

Fundamental scorecard

13 of 25 checks passed on NA’s reported financials

ValueGrowthProfitabilityHealthDividend

13of 25 checks passed

  • Value 3 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 4 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Value 3 of 5

  • No data:P/E below its own 5-year median P/E 0.9. Not enough data to decide.
  • Passed:P/E under 20 P/E 0.9: an earnings yield of 106.7%.
  • Passed:Price to sales below its own 5-year median Price to sales 4.7 against a 5-year median of 10.2.
  • Passed:Price to book below its own 5-year median Price to book 0.3 against a 5-year median of 2.0.
  • Failed:Free cash flow yield above 4% Free cash flow of -106M is -83.8% of the market value.

Growth 3 of 5

  • Failed:Revenue grew over the last year Revenue of 27.0M is -33.5% on the year before.
  • Passed:Revenue grew more than 5% a year over five years +66.2% a year from FY 2020 to FY 2025.
  • Passed:Earnings per share grew over the last year EPS 6.82 against -14.06 in the year before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -9.60 in FY 2020, 6.82 in FY 2025.
  • No data:Analysts expect higher earnings per share over the next year No analyst estimate.

Profitability 3 of 5

  • Passed:Profitable over the last year Net income of 135M over FY 2025.
  • Failed:Profitable in each of the last five fiscal years A profit in 2 of the last 5 fiscal years.
  • Passed:Return on equity above 15% Return on equity of 42.9%.
  • Passed:Net margin above its 5-year average Net margin of 501.6% against a 5-year average of -108.1%.
  • Failed:Free cash flow is at least 80% of net income Free cash flow of -106M is -78.6% of net income.

Financial health 4 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 207M against short-term liabilities of 173M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 207M against long-term liabilities of 178M.
  • Passed:Net debt under 40% of equity Net debt of 41.2M is 10.3% of equity.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -108M is -47.3% of debt.
  • Passed:Operating profit covers interest at least 3 times Operating profit is 8.7 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What NA owns and owes, as of Jun 30, 2026

Short term and long term

Balance sheet · 737M of assets

Debt, equity and cash by year

Now: 41.2M of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings, in its reporting currency.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

676.16 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 1
  • P/B 5

Valuation

P/E 3.9×
P/S 19.3×
P/B 0.7×
P/FCF -4.8×
EV/EBITDA -8.1×
EV/Sales 27.6×
FCF Yield -20.8%

Profitability

Gross Margin -147.3%
Operating Margin -396.8%
Net Margin 501.6%
ROE 18.1%
ROIC -11.0%
ROA 12.1%

Growth (YoY)

Revenue -33.5%
Operating Income -8.8%
EPS (diluted) 434.7%
Free Cash Flow 38.4%

Financial Health

Current Ratio 2.1×
Quick Ratio 2.0×
Debt / Equity 0.3×
Net Debt / EBITDA -2.5×
Interest Coverage -6.3×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31